Notícias · Recifes

A ban won't stop abortion pill access, telehealth providers say

Two developments often get lost in the public's perception of the abortion wars. One is that the number of abortions in the U.S. has increased dramatically year over year since the U.S. Supreme Court overturned Roe v. Wade in 2022, according to the Society of Family Planning's la

Admin Recifes 15/07/2026 5

Growing DRC Ebola outbreak has already spread to Uganda with high risk of reaching South S

A rare strain of Ebola that began spreading undetected in eastern Democratic Republic of Congo (DRC) in early April 2026 has now confirmed transmission in Uganda and is potentially on course to reach South Sudan, according to a new modeling study from the World Health Organizatio

Admin Recifes 15/07/2026 3

Charting palliative care priorities to recognize and support caregivers

Unpaid caregivers need greater recognition and support to continue the care they provide to their families and friends, and researchers have identified priorities outlining how to achieve this. Flinders University's Research Center for Palliative Care, Death and Dying has publish

Admin Recifes 15/07/2026 5

What happens when celebrities talk about their prostate cancer?

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media coverage raises awareness. More men may seek information or medical advice.

Admin Recifes 15/07/2026 4

Struggle to pay attention? How to tweak your life to help you focus

Ding—that's an all-too-familiar sound, designed to instantly capture your attention. The average adult receives at least 46 push notifications a day from their smartphone—roughly one every 20 minutes during waking hours.

Admin Recifes 15/07/2026 4

Early pregnancy air pollution exposure linked to persistent depressive symptoms

Exposure to common air pollutants during early pregnancy may increase the likelihood of persistent depressive symptoms throughout pregnancy, according to a new study led by Tracy Bastain and co-authored by Carrie Breton, who recently joined Bursky School of Public Health at Washi

Admin Recifes 15/07/2026 6

Young New Zealanders are waiting too long for bowel cancer diagnosis, study finds

Younger people with bowel cancer in Aotearoa are waiting months for a diagnosis, are frequently misdiagnosed and often receive little information and support, according to the largest nationwide study of its kind published in the New Zealand Medical Journal.

Admin Recifes 15/07/2026 5

Bioresorbable implant electrically stimulates organs, nerves and muscles then vanishes aft

To treat or manage various heart, gastrointestinal and neurological conditions, including arrhythmias, heart block, gastroparesis, epilepsy and some nerve injuries, doctors rely on a technique known as electrical stimulation. Electrical stimulation entails the delivery of small e

Admin Recifes 15/07/2026 5

Intravesical CAR T therapy opens door to bladder-sparing cancer treatment

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The study, published in the Journal of Experimental Medicine (

Admin Recifes 15/07/2026 4

Wildfires pose risk for premature births and low birth weight

Temperatures climb to new record highs every summer. In many parts of Europe, this marks the start of the most dangerous time of year for wildfires. What begins as a natural disaster has far-reaching consequences for the health of people in affected areas.

Admin Recifes 15/07/2026 4

Dual human antibodies stop lethal Nipah and Hendra even after infection begins

An international research team led by investigators in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai has developed the first fully human monoclonal antibody cocktail shown to provide complete protection against lethal Nipah and Hendra virus infecti

Admin Recifes 15/07/2026 3

New research may lead to a vaccine against severe diarrhea

Research led by the University of Bergen (UiB) and NORCE may help pave the way for a new vaccine targeting one of the world's leading causes of severe diarrheal disease. The technology has now been licensed to the international vaccine company Valneva, which will take the work fo

Admin Recifes 15/07/2026 4

Acompanhe as Notícias da Recifes